Paradigm Medical Communications, LLC

Paradigm Medical Communications, LLC Paradigm Medical Communications. n. Paradigm has been an ACCME-accredited provider of continuing medical education since 2007.

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. an exemplary, award-winning, medical education company that develops medical education activities using research-based needs assessments, which are innovative, well-designed, and well-executed, and that are continuously monitored to facilitate ongoing improvements. Paradigm has experience in developing and implementing CME programs in a wide variety of formats, including live events; print newsletters, monographs, and peer-reviewed journal supplements; electronic media (such as DVD); and web-based activities (including website design, development, and maintenance) as well as interdisciplinary web conferences, webinars, and podcasts. While Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians, we also have several long-standing collaborative relationships with the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC)-accredited providers that enable our activities to offer continuing education credit to the broadest range of identified target audiences. All activities developed and implemented by Paradigm Medical Communications are in adherence with the Essentials and Standards of the ACCME as well as guidelines established by the AMA, OIG, PhRMA, and FDA. Paradigm Medical Communications, LLC is dedicated to providing effective education based on the needs of the medical community. By working with thought leaders in various therapeutic areas, Paradigm Medical Communications is committed to developing impactful and innovative medical education activities designed to improve patient care strategies and patient quality of life by modifying physician behavior through the use of evidence-based, compelling, and applicable information. Cme-Accredited Provider
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. We completed our 4-year reaccreditation in 2009. Content Areas

The content areas of activities sponsored by our CME program include, but are not limited to, the following therapeutic areas: oncology, dermatology, diabetes, aesthetic medicine, hyponatremia, invasive fungal disease, infectious diseases, respiratory disease, cardiovascular disease, men's health, rheumatology, and thrombosis

Target Audience

Categories of learners targeted for education include:

US-based physicians and other health care professionals who participate in local, regional, or national activities
International health professionals who attend national conferences and/or access internet CME activities
Types of Activities

The types of activities developed include:

Live activities (symposia, local and regional meetings, hospital-based/Grand Rounds, hands-on and simulation workshops, satellite broadcasts)
Enduring materials (DVDs, peer-reviewed journal supplements, print monographs/newsletters)
Internet CME (websites, interactive cases, webinars, podcasts)
Paradigm develops activities designed to meet the preferences of our learners. This means that multiple formats are considered and implemented based on the needs of each target audience and educational intervention. Expected Results

The results expected from all educational activities are to demonstrate a change in the competence and/or performance of health care professionals and to ultimately impact patient outcomes. Continued program evaluation and assessment assists us in ensuring that activity content is relevant to learner's current educational gaps.

[1419-1] FREE NEW CME! Join this cutting-edge CME activity designed to provide guidance for medical oncologists navigati...
02/13/2026

[1419-1] FREE NEW CME! Join this cutting-edge CME activity designed to provide guidance for medical oncologists navigating the evolving landscape of HER2-low and HER2-ultralow expression in mBC. Link in bio or Scan QR code https://paradigmmed.org/1419-1INS

[1345-5] FEATURED FREE CME! How do you manage new-onset exudative macular degeneration with subretinal hemorrhage and a ...
02/13/2026

[1345-5] FEATURED FREE CME! How do you manage new-onset exudative macular degeneration with subretinal hemorrhage and a large pigment epithelial detachment requiring prompt treatment? See what your approach would be in this case where you will review the case details and sort the management choices for the case into poor, better, and best practices. Link in bio or Scan QR code https://paradigmmed.org/1345five

[1343-3] FEATURED CME! Dive into detailed patient cases to understand the complexities and nuances in treatment strategi...
02/13/2026

[1343-3] FEATURED CME! Dive into detailed patient cases to understand the complexities and nuances in treatment strategies for patients with HER2 overexpression in NSCLC in this engaging virtual activity. Scan QR code to view or visit Link in bio! Https://paradigmmed.org/1343-3

[1345-2] FEATURED CME! Join Avni Patel Finn, MD, MBA and Michael W. Stewart, MD in a lively discussion considering the s...
02/12/2026

[1345-2] FEATURED CME! Join Avni Patel Finn, MD, MBA and Michael W. Stewart, MD in a lively discussion considering the safety of these 2 new anti-vascular endothelial growth factor (VEGF) therapies. Link in bio or Scan QR code https://paradigmmed.org/1345-2

[1299] “FEATURED CME”  Tune in for a journal club discussion by Drs Dall’Era and Rovin discussing clinical implications ...
02/11/2026

[1299] “FEATURED CME” Tune in for a journal club discussion by Drs Dall’Era and Rovin discussing clinical implications of the phase 3 REGENCY trial of obinutuzumab on treatment for LN based on new guideline recommendations. Scan QR code or visit link in bio! Https://paradigmmed.org/1299

[1361-2] FEATURED CME! This webinar will present new guideline recommendations for the treatment of LN along with recent...
02/10/2026

[1361-2] FEATURED CME! This webinar will present new guideline recommendations for the treatment of LN along with recently published data from the phase 3 REGENCY trial of the novel B-cell–depleting agent obinutuzumab in LN. Scan QR code or visit link in bio!
https://paradigmmed.org/1361-2

[1434] FREE NEW CME! View now! As late-phase trials of anti-TL1A therapies for IBD progress, clinicians need to stay inf...
02/10/2026

[1434] FREE NEW CME! View now! As late-phase trials of anti-TL1A therapies for IBD progress, clinicians need to stay informed on this novel mechanism of action and its potential role in personalized treatment strategies. Anti-TL1A therapy could redefine the therapeutic landscape. Are you ready to integrate the next breakthrough? Visit Link in Bio https://paradigmmed.org/1434INS

[1335-5] FEATURED CME! Learn how a new drug indication as well as updated ASCO/CAP guidelines for HER2-low and -ultralow...
02/09/2026

[1335-5] FEATURED CME! Learn how a new drug indication as well as updated ASCO/CAP guidelines for HER2-low and -ultralow classifications will redefine the way patients with HER2 mBC are both diagnosed and treated. Visit Link in bio
Https://paradigmmed.org/1335-5

[1370] “FEATURED CME!” Test your knowledge of the diagnosis and treatment of PAH and match wits with the expert faculty ...
02/06/2026

[1370] “FEATURED CME!” Test your knowledge of the diagnosis and treatment of PAH and match wits with the expert faculty and your peers in this lighting round webinar. Link in bio or Scan QR code
https://paradigmmed.org/1370

“FEATURED CME”! View now! An educational infographic program on pathways to care in CSU. Link in bio or Scan QR code htt...
02/05/2026

“FEATURED CME”! View now! An educational infographic program on pathways to care in CSU. Link in bio or Scan QR code https:paradigmmed.org/1383INS

FEATURED CME! Explore interactive, game-based modules on obesity science, patient assessment, GLP-1 therapies, and commu...
02/05/2026

FEATURED CME! Explore interactive, game-based modules on obesity science, patient assessment, GLP-1 therapies, and communication strategies—all in one engaging CME program. Start learning now! Link in bio or Scan QR code Https://paradigmmed.org/1371-1INS

[1167] LAST CHANCE - FREE CME! Special Delivery: Novel and Emerging Devices and Therapies That Allow for Sustained Treat...
02/04/2026

[1167] LAST CHANCE - FREE CME! Special Delivery: Novel and Emerging Devices and Therapies That Allow for Sustained Treatment of Retinal Diseases. Link in bio or Scan QR code https://paradigmmed.org/1167

Address

523 Route 303
Orangeburg, NY
10962

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Alerts

Be the first to know and let us send you an email when Paradigm Medical Communications, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Paradigm Medical Communications, LLC:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram